GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
S

Shanghai Kinetic Medical Co 300326.SZ · CNY

Health Care · Shenzhen · 🇨🇳 China

Compare

6.63

+0.91%

Close of 9 Nov 2026, in CNY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in CNY, from our data supplier.

FY2025

Revenue

CN¥963.1m

FY2016FY2025

Net income

CN¥134.9m

FY2016FY2025

Free cash flow

CN¥122.9m

FY2016FY2025

Shareholders' equity

CN¥2.86bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueCN¥963.1mCN¥984.5mCN¥956.3mCN¥1.17bnCN¥1.27bnCN¥1.06bnCN¥1.22bnCN¥930.9mCN¥802.3mCN¥550.6m
Research and developmentCN¥51.4mCN¥43.3mCN¥59.3mCN¥61.4mCN¥69.8mCN¥46.6mCN¥48.7mCN¥43.5mCN¥38.6mCN¥31.9m
Operating incomeCN¥151.2m−CN¥100.3mCN¥140.1mCN¥97,690CN¥218.8m−CN¥74.8mCN¥359.2mCN¥497.6mCN¥246.5mCN¥192.5m
Net incomeCN¥134.9m−CN¥105.6mCN¥112.5m−CN¥21.3mCN¥161.8m−CN¥126.5mCN¥302.3mCN¥462.6mCN¥195.0mCN¥158.8m
Diluted earnings per share0.19-0.150.16-0.030.23-0.170.420.640.270.19

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsCN¥3.07bnCN¥3.35bnCN¥3.35bnCN¥3.41bnCN¥3.51bnCN¥3.68bnCN¥3.77bnCN¥3.57bnCN¥2.69bnCN¥2.22bn
Cash and short-term investments—CN¥1.22bnCN¥1.04bnCN¥971.9mCN¥906.8mCN¥866.3mCN¥926.0mCN¥1.05bnCN¥327.2mCN¥465.2m
Total liabilitiesCN¥181.0mCN¥532.0mCN¥405.4mCN¥597.4mCN¥731.1mCN¥993.5mCN¥1.02bnCN¥1.07bnCN¥652.9mCN¥375.6m
Debt—CN¥297.1mCN¥172.7mCN¥321.1mCN¥416.2mCN¥638.7mCN¥595.5mCN¥695.6mCN¥346.5mCN¥267.9m
Shareholders' equityCN¥2.86bnCN¥2.72bnCN¥2.86bnCN¥2.74bnCN¥2.73bnCN¥2.64bnCN¥2.75bnCN¥2.50bnCN¥2.03bnCN¥1.84bn
Shares outstanding716m718m707m716m718m724m723m719m721m828m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operationsCN¥189.1mCN¥157.8mCN¥274.3mCN¥236.8mCN¥378.2mCN¥284.9mCN¥255.6mCN¥95.3mCN¥146.9mCN¥130.4m
Capital spending−CN¥66.2m−CN¥82.8m−CN¥53.8m−CN¥41.5m−CN¥49.2m−CN¥29.6m−CN¥40.3m−CN¥37.8m−CN¥39.0m−CN¥38.9m
Free cash flowCN¥122.9mCN¥74.9mCN¥220.5mCN¥195.3mCN¥328.9mCN¥255.3mCN¥215.3mCN¥57.5mCN¥107.9mCN¥91.5m
Dividends paid−CN¥4.6m−CN¥46.1m−CN¥5.1m−CN¥35.5m−CN¥35.9m−CN¥56.1m−CN¥50.6m−CN¥42.2m−CN¥33.2m−CN¥33.4m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueCN¥189.3mCN¥171.0mCN¥175.1mCN¥241.9mCN¥281.3mCN¥264.8mCN¥234.3mCN¥274.3m
Operating incomeCN¥54.6mCN¥28.3mCN¥25.3mCN¥32.5mCN¥20.7mCN¥30.8m−CN¥191.0mCN¥36.6m
Net incomeCN¥67.8mCN¥66.1mCN¥63.6mCN¥27.4mCN¥22.1mCN¥21.8m−CN¥161.6mCN¥25.8m
Diluted earnings per share0.090.090.090.040.030.03-0.230.04
Cash from operations———CN¥73.0mCN¥36.0mCN¥8.0m—CN¥61.0m
Capital spending−CN¥6.0m−CN¥2.0m−CN¥9.0m−CN¥14.0m−CN¥17.0m−CN¥24.0m−CN¥26.0m−CN¥25.0m
Free cash flow———CN¥59.0mCN¥19.0m−CN¥16.0m—CN¥36.0m
Total assetsCN¥3.11bnCN¥3.13bnCN¥3.07bnCN¥3.38bnCN¥3.35bnCN¥3.34bnCN¥3.35bnCN¥3.41bn
Cash and short-term investments———CN¥1.29bnCN¥1.24bnCN¥1.16bnCN¥1.22bnCN¥1.07bn
Debt———CN¥233.8mCN¥233.8mCN¥210.9mCN¥235.8mCN¥192.5m
Shareholders' equityCN¥2.91bnCN¥2.92bnCN¥2.86bnCN¥2.79bnCN¥2.77bnCN¥2.75bnCN¥2.72bnCN¥2.86bn

Financial ratios

Data as of 18 Oct 2026

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Operating margin15.9%-10.2%14.7%1.0%18.8%-6.1%—
Net margin14.0%-10.7%11.8%-1.8%12.8%-11.9%—
Return on equity4.7%-3.9%3.9%-0.8%5.9%-4.8%—
Return on assets4.4%-3.2%3.4%-0.6%4.6%-3.4%—
Free cash flow yield5.5%5.2%7.2%6.0%9.3%6.8%—
Revenue growth-2.2%3.0%-18.0%-8.1%19.5%-13.1%—
Earnings growth-227.8%-193.8%-628.8%-113.2%-227.8%-141.9%—
Current ratio12.47x4.25x5.19x3.35x3.16x1.98x—
Debt to equity—0.09x0.04x0.06x0.10x0.10x0.21x
Equity ratio93.1%81.2%85.3%80.3%77.9%71.8%—
Interest coverage20.47x-10.00x12.95x0.65x9.40x-2.38x—
R&D as a share of sales5.3%4.4%6.2%5.3%5.5%4.4%—
Buybacks as a share of market value0.2%-1.5%1.3%0.3%0.7%-0.1%—

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-6.2%-1.9%7.6%
Operating income1056.6%—-1.0%
Net income——1.1%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin2.6%4.7%5.2%17.3%
Net margin1.5%3.0%2.4%13.5%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings30.2-44.239.8-242.347.3-90.632.413.230.958.0
Price to sales4.24.74.74.46.010.88.06.67.516.7

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years. Last went ex-dividend on 16 Jul 2024.

FY2024FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Paid in the year0.060.050.050.050.0710.030.0250.028
  • 1.794-for-1 split · 21 Oct 2016
  • 2-for-1 split · 26 Jun 2015
  • 2-for-1 split · 16 Jun 2014
  • 3-for-2 split · 13 May 2013

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.